NeuroVax

BIOLOGICAL3 trials

Sponsors

Immune Response BioPharma, Inc.

Conditions

Multiple SclerosisSecondary Progress Multiple Sclerosis

Phase 1

A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

Immune Response BioPharma, Inc.Multiple Sclerosis

Start: 2020-12-31End: 2024-11-09Target: 12Updated: 2020-03-31

Phase 2

A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Immune Response BioPharma, Inc.Multiple Sclerosis, Secondary Progress Multiple Sclerosis

Start: 2020-03-09End: 2023-03-09Target: 200Updated: 2020-03-11

A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Immune Response BioPharma, Inc.Multiple Sclerosis

Start: 2020-03-09End: 2022-03-09Target: 150Updated: 2020-03-11